Jutta Deckert
Vice President, Research & Development Iksuda Therapeutics
Seminars
Thursday 14th May 2026
Understanding Clinically Relevant Dose Selection for ADCs Using Toxicology Data
10:30 am
- Review the ADC landscape to understand translatability of ADC platform toxicities
- Integrate off-target and on-target findings
- Therapeutic window prediction by selecting appropriate preclinical efficacy models and dosing schedules
